These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1303612

  • 1. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P.
    Cancer; 1992 Jan 15; 69(2):327-34. PubMed ID: 1303612
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 3. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C, Levi F, Kreutz F, Focan-Henrard D, Lobelle JP, Adam R, Dallemagne B, Jehaes C, Markiewicz S, Weerts J, Bismuth H, Jasmin C, Misset JL.
    Anticancer Drugs; 1999 Apr 15; 10(4):385-92. PubMed ID: 10378673
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
    Kemeny N, Conti JA, Cohen A, Campana P, Huang Y, Shi WJ, Botet J, Pulliam S, Bertino JR.
    J Clin Oncol; 1994 Nov 15; 12(11):2288-95. PubMed ID: 7964942
    [Abstract] [Full Text] [Related]

  • 5. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
    House MG, Kemeny NE, Gönen M, Fong Y, Allen PJ, Paty PB, DeMatteo RP, Blumgart LH, Jarnagin WR, D'Angelica MI.
    Ann Surg; 2011 Dec 15; 254(6):851-6. PubMed ID: 21975318
    [Abstract] [Full Text] [Related]

  • 6. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 7. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M, Müller HH.
    J Clin Oncol; 2000 Jan 01; 18(2):243-54. PubMed ID: 10637236
    [Abstract] [Full Text] [Related]

  • 8. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.
    Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER.
    Ann Surg Oncol; 1995 Mar 01; 2(2):114-20. PubMed ID: 7537164
    [Abstract] [Full Text] [Related]

  • 9. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Gonen M, Stockman J, Blumgart L, Sperber D, Hummer A, Fong Y.
    J Clin Oncol; 2003 Sep 01; 21(17):3303-9. PubMed ID: 12947066
    [Abstract] [Full Text] [Related]

  • 10. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
    Sigurdson ER, Ridge JA, Daly JM.
    Surgery; 1986 Aug 01; 100(2):285-91. PubMed ID: 2943036
    [Abstract] [Full Text] [Related]

  • 11. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE.
    J Clin Oncol; 1998 Jul 01; 16(7):2528-33. PubMed ID: 9667274
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Campos LT.
    Cancer; 1993 Feb 01; 71(3):875-6. PubMed ID: 8431872
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ, Boddie AW, Charnsangavej C, Ajani JA, Wallace S, Soski M, Claghorn L, Mavligit GM.
    J Clin Oncol; 1986 Sep 01; 4(9):1356-64. PubMed ID: 2943876
    [Abstract] [Full Text] [Related]

  • 14. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH.
    Cancer; 1989 Jul 15; 64(2):379-87. PubMed ID: 2525415
    [Abstract] [Full Text] [Related]

  • 15. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.
    Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.
    Ann Surg Oncol; 2011 Jul 15; 18(7):1924-31. PubMed ID: 21207165
    [Abstract] [Full Text] [Related]

  • 16. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.
    Gan To Kagaku Ryoho; 1999 Feb 15; 26(3):269-81. PubMed ID: 10065089
    [Abstract] [Full Text] [Related]

  • 17. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study.
    Bertuccelli M, Falcone A, Campoccia S, Conti M, Brunetti I, Caramella D, Giulianotti PC, Mosca F, Bartolozzi C, Conte PF.
    Tumori; 1999 Feb 15; 85(6):473-7. PubMed ID: 10774568
    [Abstract] [Full Text] [Related]

  • 18. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.
    Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, Stockman J, Fong Y, Jarnagin W, Bertino J, Tong W, Paty P.
    J Clin Oncol; 2001 May 15; 19(10):2687-95. PubMed ID: 11352961
    [Abstract] [Full Text] [Related]

  • 19. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG.
    Eur J Surg Oncol; 1999 Aug 15; 25(4):381-8. PubMed ID: 10419708
    [Abstract] [Full Text] [Related]

  • 20. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Aug 15; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.